{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:24:12Z","timestamp":1793384652003,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Joint Foundation of the Health Commission of Hubei Province","award":["WJ2018H173"],"award-info":[{"award-number":["WJ2018H173"]}],"id":[{"id":"https:\/\/ror.org\/02g4yc525","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Central Funds Guiding the Local Science and Technology Development of Hubei Province","award":["2019ZYYD066"],"award-info":[{"award-number":["2019ZYYD066"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271872"],"award-info":[{"award-number":["81271872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Schistosomiasis is a prevalent parasitic disease worldwide. The main pathological changes of hepatosplenic schistosomiasis are hepatic granuloma and fibrosis due to worm eggs. Portal hypertension and ascites induced by hepatic fibrosis are usually the main causes of death in patients with chronic hepatosplenic schistosomiasis. Currently, no effective vaccine exists for preventing schistosome infections. For quite a long time, praziquantel (PZQ) was widely used for the treatment of schistosomiasis and has shown benefit in treating liver fibrosis. However, drug resistance and chemical toxicity from PZQ are being increasingly reported in recent years; therefore, new and effective strategies for treating schistosomiasis-induced hepatic fibrosis are urgently needed. MicroRNA (miRNA), a non-coding RNA, has been proved to be associated with the development of many human diseases, including schistosomiasis. In this review, we present a balanced and comprehensive view of the role of miRNAs in the pathogenesis, grading, and treatment of schistosomiasis-associated hepatic fibrosis. The multiple regulatory roles of miRNAs, such as promoting or inhibiting the development of liver pathology in murine schistosomiasis are also discussed in depth. Additionally, miRNAs may serve as candidate biomarkers for diagnosing liver pathology of schistosomiasis and as novel therapeutic targets for treating schistosomiasis-associated hepatic fibrosis.<\/jats:p>","DOI":"10.1186\/s13071-019-3866-0","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T11:02:51Z","timestamp":1577703771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis"],"prefix":"10.1186","volume":"12","author":[{"given":"Qianglin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4094-7883","authenticated-orcid":false,"given":"Quan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"3866_CR1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.pt.2017.07.007","volume":"33","author":"M Egesa","year":"2017","unstructured":"Egesa M, Hoffmann KF, Hokke CH, Yazdanbakhsh M, Cose S. Rethinking schistosomiasis vaccine development: synthetic vesicles. Trends Parasitol. 2017;33:918\u201321.","journal-title":"Trends Parasitol."},{"key":"3866_CR2","doi-asserted-by":"publisher","first-page":"e0120792","DOI":"10.1371\/journal.pone.0120792","volume":"10","author":"Y Dai","year":"2015","unstructured":"Dai Y, Wang X, Tang J, Zhao S, Xing Y, Dai J, et al. Enhancement of protective efficacy through adenoviral vectored vaccine priming and protein boosting strategy encoding triosephosphate isomerase (SjTPI) against Schistosoma japonicum in mice. PLoS ONE. 2015;10:e0120792.","journal-title":"PLoS ONE."},{"key":"3866_CR3","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253\u201364.","journal-title":"Lancet."},{"key":"3866_CR4","doi-asserted-by":"publisher","first-page":"e0004684","DOI":"10.1371\/journal.pntd.0004684","volume":"10","author":"P Cai","year":"2016","unstructured":"Cai P, Liu S, Piao X, Hou N, Gobert GN, McManus DP, et al. Comprehensive transcriptome analysis of sex-biased expressed genes reveals discrete biological and physiological features of male and female Schistosoma japonicum. PLoS Negl Trop Dis. 2016;10:e0004684.","journal-title":"PLoS Negl Trop Dis."},{"key":"3866_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijpara.2016.01.002","volume":"46","author":"P Cai","year":"2016","unstructured":"Cai P, Gobert GN, You H, McManus DP. The Tao survivorship of schistosomes: implications for schistosomiasis control. Int J Parasitol. 2016;46:453\u201363.","journal-title":"Int J Parasitol."},{"key":"3866_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/tropicalmed4010044","volume":"4","author":"K Pisarski","year":"2019","unstructured":"Pisarski K. The global burden of disease of zoonotic parasitic diseases: top 5 contenders for priority consideration. Trop Med Infect Dis. 2019;4:44.","journal-title":"Trop Med Infect Dis."},{"key":"3866_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2018.11.011","volume":"206","author":"VR da Paz","year":"2019","unstructured":"da Paz VR, Figueiredo-Vanzan D, dos Santos Pyrrho A. Interaction and involvement of cellular adhesion molecules in the pathogenesis of Schistosomiasis mansoni. Immunol Lett. 2019;206:11\u20138.","journal-title":"Immunol Lett."},{"key":"3866_CR8","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3389\/fimmu.2018.02580","volume":"9","author":"D Cortes-Selva","year":"2018","unstructured":"Cortes-Selva D, Elvington AF, Ready A, Rajwa B, Pearce EJ, Randolph GJ, et al. Schistosoma mansoni infection-induced transcriptional changes in hepatic macrophage metabolism correlate with an athero-protective phenotype. Front Immunol. 2018;9:2580.","journal-title":"Front Immunol."},{"key":"3866_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fmicb.2019.00066","volume":"10","author":"B Zhang","year":"2019","unstructured":"Zhang B, Wu X, Liu J, Song L, Song Q, Wang L, et al. beta-Actin: not a suitable internal control of hepatic fibrosis caused by Schistosoma japonicum. Front Microbiol. 2019;10:66.","journal-title":"Front Microbiol."},{"key":"3866_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.pt.2012.09.005","volume":"28","author":"BJ Anthony","year":"2012","unstructured":"Anthony BJ, Ramm GA, McManus DP. Role of resident liver cells in the pathogenesis of schistosomiasis. Trends Parasitol. 2012;28:572\u20139.","journal-title":"Trends Parasitol."},{"key":"3866_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejphar.2018.02.051","volume":"826","author":"MM Ni","year":"2018","unstructured":"Ni MM, Wang YR, Wu WW, Xia CC, Zhang YH, Xu J, et al. Novel insights on notch signaling pathways in liver fibrosis. Eur J Pharmacol. 2018;826:66\u201374.","journal-title":"Eur J Pharmacol."},{"key":"3866_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.parint.2015.07.002","volume":"64","author":"X He","year":"2015","unstructured":"He X, Bao J, Chen J, Sun X, Wang J, Zhu D, et al. Adenovirus-mediated over-expression of Septin4 ameliorates hepatic fibrosis in mouse livers infected with Schistosoma japonicum. Parasitol Int. 2015;64:487\u201392.","journal-title":"Parasitol Int."},{"key":"3866_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2147\/IDR.S196544","volume":"12","author":"AM El-Kady","year":"2019","unstructured":"El-Kady AM, Ahmad AA, Hassan TM, El-Deek HEM, Fouad SS, Althagfan SS. Eugenol, a potential schistosomicidal agent with anti-inflammatory and antifibrotic effects against Schistosoma mansoni, induced liver pathology. Infect Drug Resist. 2019;12:709\u201319.","journal-title":"Infect Drug Resist."},{"key":"3866_CR14","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s00436-018-5972-x","volume":"117","author":"Z Ma","year":"2018","unstructured":"Ma Z, Liu X, Dong H, Xia D, Wang L, Chen Y, et al. Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice. Parasitol Res. 2018;117:2831\u20139.","journal-title":"Parasitol Res."},{"key":"3866_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pt.2015.03.009","volume":"31","author":"J Hagen","year":"2015","unstructured":"Hagen J, Scheerlinck JP, Gasser RB. Knocking down schistosomes - promise for lentiviral transduction in parasites. Trends Parasitol. 2015;31:324\u201332.","journal-title":"Trends Parasitol."},{"key":"3866_CR16","doi-asserted-by":"publisher","first-page":"e20247","DOI":"10.1371\/journal.pone.0020247","volume":"6","author":"YJ Liang","year":"2011","unstructured":"Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, et al. New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS ONE. 2011;6:e20247.","journal-title":"PLoS ONE."},{"key":"3866_CR17","doi-asserted-by":"publisher","first-page":"e00005","DOI":"10.1128\/AAC.00005-17","volume":"62","author":"D Kong","year":"2017","unstructured":"Kong D, Zhou C, Guo H, Wang W, Qiu J, Liu X, et al. Praziquantel targets M1 macrophages and ameliorates splenomegaly in chronic schistosomiasis. Antimicrob Agents Chemother. 2017;62:e00005\u201317.","journal-title":"Antimicrob Agents Chemother."},{"key":"3866_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.actatropica.2019.02.027","volume":"194","author":"SN El-Beshbishi","year":"2019","unstructured":"El-Beshbishi SN, Saleh NE, Abd El-Mageed SA, El-Nemr HEE, Abdalla HA, Shebl AM, et al. Effect of omega-3 fatty acids administered as monotherapy or combined with artemether on experimental Schistosoma mansoni infection. Acta Trop. 2019;194:62\u20138.","journal-title":"Acta Trop."},{"key":"3866_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/biom9020054","volume":"9","author":"MJ Gouveia","year":"2019","unstructured":"Gouveia MJ, Brindley PJ, Rinaldi G, Gartner F, da Costa JM, Vale N. Combination anthelmintic\/antioxidant activity against Schistosoma Mansoni. Biomolecules. 2019;9:54.","journal-title":"Biomolecules."},{"key":"3866_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12967-019-1907-2","volume":"17","author":"C Benna","year":"2019","unstructured":"Benna C, Rajendran S, Rastrelli M, Mocellin S. miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis. J Transl Med. 2019;17:153.","journal-title":"J Transl Med."},{"key":"3866_CR21","first-page":"3530647","volume":"2018","author":"X Zhang","year":"2018","unstructured":"Zhang X, Hua F, Yang Z, Chen Y, Teng X, Huang H, et al. Enhancement of immunoregulatory function of modified bone marrow mesenchymal stem cells by targeting SOCS1. Biomed Res Int. 2018;2018:3530647.","journal-title":"Biomed Res Int."},{"key":"3866_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/imm.12994","volume":"155","author":"C Liu","year":"2018","unstructured":"Liu C, Yang H, Shi W, Wang T, Ruan Q. MicroRNA-mediated regulation of T helper type 17\/regulatory T-cell balance in autoimmune disease. Immunology. 2018;155:427\u201334.","journal-title":"Immunology."},{"key":"3866_CR23","doi-asserted-by":"publisher","first-page":"e0181483","DOI":"10.1371\/journal.pone.0181483","volume":"12","author":"FR Queiroz","year":"2017","unstructured":"Queiroz FR, Silva LM, Jeremias WJ, Baba EH, Caldeira RL, Coelho PMZ, et al. Differential expression of small RNA pathway genes associated with the Biomphalaria glabrata\/Schistosoma mansoni interaction. PLoS ONE. 2017;12:e0181483.","journal-title":"PLoS ONE."},{"key":"3866_CR24","doi-asserted-by":"crossref","first-page":"17459","DOI":"10.1002\/jcp.28367","volume":"234","author":"R Rouas","year":"2019","unstructured":"Rouas R, Merimi M, Najar M, El Zein N, Fayyad-Kazan M, Berehab M, et al. Human CD8(+) CD25 (+) CD127 (low) regulatory T cells: microRNA signature and impact on TGF-beta and IL-10 expression. J Cell Physiol. 2019;234:17459\u201372.","journal-title":"J Cell Physiol."},{"key":"3866_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-62703-748-8_3","volume":"1107","author":"KU Tufekci","year":"2014","unstructured":"Tufekci KU, Oner MG, Meuwissen RL, Genc S. The role of microRNAs in human diseases. Methods Mol Biol. 2014;1107:33\u201350.","journal-title":"Methods Mol Biol."},{"key":"3866_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/bs.acr.2017.06.002","volume":"135","author":"K Van Roosbroeck","year":"2017","unstructured":"Van Roosbroeck K, Calin GA. Cancer hallmarks and microRNAs: the therapeutic connection. Adv Cancer Res. 2017;135:119\u201349.","journal-title":"Adv Cancer Res."},{"key":"3866_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","volume":"15","author":"JQ Chen","year":"2016","unstructured":"Chen JQ, Papp G, Szodoray P, Zeher M. The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev. 2016;15:1171\u201380.","journal-title":"Autoimmun Rev."},{"key":"3866_CR28","first-page":"586","volume":"8","author":"N Arora","year":"2017","unstructured":"Arora N, Tripathi S, Singh AK, Mondal P, Mishra A, Prasad A. Micromanagement of immune system: role of miRNAs in helminthic infections. Front Microbiol. 2017;8:586.","journal-title":"Front Microbiol."},{"key":"3866_CR29","doi-asserted-by":"publisher","first-page":"e12416","DOI":"10.1111\/pim.12416","volume":"39","author":"Y Hong","year":"2017","unstructured":"Hong Y, Fu Z, Cao X, Lin J. Changes in microRNA expression in response to Schistosoma japonicum infection. Parasite Immunol. 2017;39:e12416.","journal-title":"Parasite Immunol."},{"key":"3866_CR30","doi-asserted-by":"publisher","first-page":"e67037","DOI":"10.1371\/journal.pone.0067037","volume":"8","author":"P Cai","year":"2013","unstructured":"Cai P, Piao X, Liu S, Hou N, Wang H, Chen Q. MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection. PLoS ONE. 2013;8:e67037.","journal-title":"PLoS ONE."},{"key":"3866_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","volume":"90","author":"SC Yanguas","year":"2016","unstructured":"Yanguas SC, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, et al. Experimental models of liver fibrosis. Arch Toxicol. 2016;90:1025\u201348.","journal-title":"Arch Toxicol."},{"key":"3866_CR32","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","volume":"16","author":"HZ Ying","year":"2017","unstructured":"Ying HZ, Chen Q, Zhang WY, Zhang HH, Ma Y, Zhang SZ, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics. Mol Med Rep. 2017;16:7879\u201389.","journal-title":"Mol Med Rep."},{"key":"3866_CR33","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/hep.29627","volume":"67","author":"JM Caviglia","year":"2018","unstructured":"Caviglia JM, Yan J, Jang MK, Gwak GY, Affo S, Yu L, et al. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology. 2018;67:2414\u201329.","journal-title":"Hepatology."},{"key":"3866_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","volume":"67","author":"J Wei","year":"2013","unstructured":"Wei J, Feng L, Li Z, Xu G, Fan X. MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling. Biomed Pharmacother. 2013;67:387\u201392.","journal-title":"Biomed Pharmacother."},{"key":"3866_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41418-017-0019-x","volume":"25","author":"MB Afonso","year":"2018","unstructured":"Afonso MB, Rodrigues PM, Simao AL, Gaspar MM, Carvalho T, Borralho P, et al. miRNA-21 ablation protects against liver injury and necroptosis in cholestasis. Cell Death Differ. 2018;25:857\u201372.","journal-title":"Cell Death Differ."},{"key":"3866_CR36","first-page":"800","volume":"5","author":"RX Chen","year":"2012","unstructured":"Chen RX, Xia YH, Xue TC, Ye SL. Suppression of microRNA-96 expression inhibits the invasion of hepatocellular carcinoma cells. Mol Med Rep. 2012;5:800\u20134.","journal-title":"Mol Med Rep."},{"key":"3866_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1139\/bcb-2017-0183","volume":"96","author":"Z Li","year":"2018","unstructured":"Li Z, Wang Y. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma. Biochem Cell Biol. 2018;96:365\u201371.","journal-title":"Biochem Cell Biol."},{"key":"3866_CR38","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3748\/wjg.v19.i9.1405","volume":"19","author":"BL Chen","year":"2013","unstructured":"Chen BL, Peng J, Li QF, Yang M, Wang Y, Chen W. Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-beta\/Smad signaling. World J Gastroenterol. 2013;19:1405\u201315.","journal-title":"World J Gastroenterol."},{"key":"3866_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.pt.2018.02.005","volume":"34","author":"JP Carson","year":"2018","unstructured":"Carson JP, Ramm GA, Robinson MW, McManus DP, Gobert GN. Schistosome-induced fibrotic disease: the role of hepatic stellate cells. Trends Parasitol. 2018;34:524\u201340.","journal-title":"Trends Parasitol."},{"key":"3866_CR40","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/hep.27671","volume":"61","author":"X He","year":"2015","unstructured":"He X, Xie J, Zhang D, Su Q, Sai X, Bai R, et al. Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways. Hepatology. 2015;61:2008\u201317.","journal-title":"Hepatology."},{"key":"3866_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.omtm.2018.10.002","volume":"11","author":"X Luo","year":"2018","unstructured":"Luo X, Zhang D, Xie J, Su Q, He X, Bai R, et al. MicroRNA-96 promotes schistosomiasis hepatic fibrosis in mice by suppressing Smad7. Mol Ther Methods Clin Dev. 2018;11:73\u201382.","journal-title":"Mol Ther Methods Clin Dev."},{"key":"3866_CR42","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.3892\/etm.2016.3856","volume":"12","author":"Q He","year":"2016","unstructured":"He Q, Qiu J, Dai M, Fang Q, Sun X, Gong Y, et al. MicroRNA-351 inhibits denervation-induced muscle atrophy by targeting TRAF6. Exp Ther Med. 2016;12:4029\u201334.","journal-title":"Exp Ther Med."},{"key":"3866_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4161\/rna.19100","volume":"9","author":"X Li","year":"2012","unstructured":"Li X, Feng R, Huang C, Wang H, Wang J, Zhang Z, et al. MicroRNA-351 regulates TMEM 59 (DCF1) expression and mediates neural stem cell morphogenesis. RNA Biol. 2012;9:292\u2013301.","journal-title":"RNA Biol."},{"key":"3866_CR44","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1096\/fj.201800151RR","volume":"32","author":"LN Zhang","year":"2018","unstructured":"Zhang LN, Tian H, Zhou XL, Tian SC, Zhang XH, Wu TJ. Upregulation of microRNA-351 exerts protective effects during sepsis by ameliorating skeletal muscle wasting through the Tead-4-mediated blockade of the Hippo signaling pathway. FASEB J. 2018;32:6934\u201347.","journal-title":"FASEB J."},{"key":"3866_CR45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1073\/pnas.1715965115","volume":"115","author":"X He","year":"2018","unstructured":"He X, Sun Y, Lei N, Fan X, Zhang C, Wang Y, et al. MicroRNA-351 promotes schistosomiasis-induced hepatic fibrosis by targeting the vitamin D receptor. Proc Natl Acad Sci USA. 2018;115:180\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3866_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ebiom.2016.10.024","volume":"13","author":"X He","year":"2016","unstructured":"He X, Tang R, Sun Y, Wang YG, Zhen KY, Zhang DM, et al. MicroR-146 blocks the activation of M1 macrophage by targeting signal transducer and activator of transcription 1 in hepatic schistosomiasis. EBioMedicine. 2016;13:339\u201347.","journal-title":"EBioMedicine."},{"key":"3866_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/187152809789352230","volume":"8","author":"F Heymann","year":"2009","unstructured":"Heymann F, Trautwein C, Tacke F. Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy Drug Targets. 2009;8:307\u201318.","journal-title":"Inflamm Allergy Drug Targets."},{"key":"3866_CR48","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang CY, Yuan WG, He P, Lei JH, Wang CX. Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol. 2016;22:10512\u201322.","journal-title":"World J Gastroenterol."},{"key":"3866_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","volume":"20","author":"DR Herbert","year":"2004","unstructured":"Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20:623\u201335.","journal-title":"Immunity."},{"key":"3866_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-3024.2007.00973.x","volume":"29","author":"JL Reyes","year":"2007","unstructured":"Reyes JL, Terrazas LI. The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol. 2007;29:609\u201319.","journal-title":"Parasite Immunol."},{"key":"3866_CR51","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1172\/JCI36150","volume":"118","author":"SD Ricardo","year":"2008","unstructured":"Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest. 2008;118:3522\u201330.","journal-title":"J Clin Invest."},{"key":"3866_CR52","doi-asserted-by":"publisher","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","volume":"5","author":"JT Pesce","year":"2009","unstructured":"Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009;5:e1000371.","journal-title":"PLoS Pathog."},{"key":"3866_CR53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.intimp.2019.02.032","volume":"70","author":"MV Dias","year":"2019","unstructured":"Dias MV, Castro AP, Campos CC, Souza-Silva TG, Goncalves RV, Souza RLM, et al. Doxycycline hyclate: A schistosomicidal agent in vitro with immunomodulatory potential on granulomatous inflammation in vivo. Int Immunopharmacol. 2019;70:324\u201337.","journal-title":"Int Immunopharmacol."},{"key":"3866_CR54","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/eji.201141869","volume":"41","author":"L Barron","year":"2011","unstructured":"Barron L, Wynn TA. Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur J Immunol. 2011;41:2509\u201314.","journal-title":"Eur J Immunol."},{"key":"3866_CR55","first-page":"6398078","volume":"2018","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Ni Y, Liu R, Hou M, Yang B, Song J, et al. PPAR-gamma agonist alleviates liver and spleen pathology via inducing Treg cells during Schistosoma japonicum infection. J Immunol Res. 2018;2018:6398078.","journal-title":"J Immunol Res."},{"key":"3866_CR56","doi-asserted-by":"publisher","first-page":"e0007000","DOI":"10.1371\/journal.pntd.0007000","volume":"12","author":"W Gong","year":"2018","unstructured":"Gong W, Huang F, Sun L, Yu A, Zhang X, Xu Y, et al. Toll-like receptor-2 regulates macrophage polarization induced by excretory-secretory antigens from Schistosoma japonicum eggs and promotes liver pathology in murine schistosomiasis. PLoS Negl Trop Dis. 2018;12:e0007000.","journal-title":"PLoS Negl Trop Dis."},{"key":"3866_CR57","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3389\/fimmu.2018.01572","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu L, Jin M, Tao Q, Yu L, Du J, Wang C, et al. Effective amelioration of liver fibrosis through lentiviral vector carrying Toxoplasma gondii gra15II in murine model. Front Immunol. 2018;9:1572.","journal-title":"Front Immunol."},{"key":"3866_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ebiom.2016.11.005","volume":"13","author":"B Everts","year":"2016","unstructured":"Everts B. Micro(RNAs)managing macrophage polarization during schistosomiasis. EBioMedicine. 2016;13:33\u20134.","journal-title":"EBioMedicine."},{"key":"3866_CR59","first-page":"4670","volume":"17","author":"Z Yang","year":"2019","unstructured":"Yang Z, Peng Y, Yang S. MicroRNA-146a regulates the transformation from liver fibrosis to cirrhosis in patients with hepatitis B via interleukin-6. Exp Ther Med. 2019;17:4670\u20136.","journal-title":"Exp Ther Med."},{"key":"3866_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2017.07.016","volume":"39","author":"Y Zou","year":"2017","unstructured":"Zou Y, Cai Y, Lu D, Zhou Y, Yao Q, Zhang S. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFbeta1 and lipopolysaccharide. Cell Signal. 2017;39:1\u20138.","journal-title":"Cell Signal."},{"key":"3866_CR61","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3389\/fimmu.2017.01062","volume":"8","author":"JB Self-Fordham","year":"2017","unstructured":"Self-Fordham JB, Naqvi AR, Uttamani JR, Kulkarni V, Nares S. MicroRNA: Dynamic regulators of Macrophage polarization and plasticity. Front Immunol. 2017;8:1062.","journal-title":"Front Immunol."},{"key":"3866_CR62","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.aohep.2018.12.001","volume":"18","author":"V Gonzalez-Polo","year":"2019","unstructured":"Gonzalez-Polo V, Pucci-Molineris M, Cervera V, Gambaro S, Yantorno SE, Descalzi V, et al. Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis. Ann Hepatol. 2019;18:366\u201372.","journal-title":"Ann Hepatol."},{"key":"3866_CR63","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3389\/fimmu.2018.02432","volume":"9","author":"OS Kotsiou","year":"2018","unstructured":"Kotsiou OS, Gourgoulianis KI, Zarogiannis SG. IL-33\/ST2 axis in organ fibrosis. Front Immunol. 2018;9:2432.","journal-title":"Front Immunol."},{"key":"3866_CR64","doi-asserted-by":"publisher","first-page":"7947596","DOI":"10.1155\/2019\/7947596","volume":"2019","author":"JM Shieh","year":"2019","unstructured":"Shieh JM, Tseng HY, Jung F, Yang SH, Lin JC. Elevation of IL-6 and IL-33 levels in serum associated with lung fibrosis and skeletal muscle wasting in a bleomycin-induced lung injury mouse model. Mediators Inflamm. 2019;2019:7947596.","journal-title":"Mediators Inflamm."},{"key":"3866_CR65","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.bbadis.2019.06.015","volume":"1865","author":"L Liu","year":"2019","unstructured":"Liu L, Mao L, Wu X, Wu T, Liu W, Yang Y, et al. BRG1 regulates endothelial-derived IL-33 to promote ischemia-reperfusion induced renal injury and fibrosis in mice. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2551\u201361.","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"3866_CR66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.yjmcc.2019.01.018","volume":"128","author":"JC Garbern","year":"2019","unstructured":"Garbern JC, Williams J, Kristl AC, Malick A, Rachmin I, Gaeta B, et al. Dysregulation of IL-33\/ST2 signaling and myocardial periarteriolar fibrosis. J Mol Cell Cardiol. 2019;128:179\u201386.","journal-title":"J Mol Cell Cardiol."},{"key":"3866_CR67","doi-asserted-by":"publisher","first-page":"e1006957","DOI":"10.1371\/journal.ppat.1006957","volume":"14","author":"X He","year":"2018","unstructured":"He X, Xie J, Wang Y, Fan X, Su Q, Sun Y, et al. Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33. PLoS Pathog. 2018;14:e1006957.","journal-title":"PLoS Pathog."},{"key":"3866_CR68","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13071-019-3542-4","volume":"12","author":"ZY Li","year":"2019","unstructured":"Li ZY, Xiao L, Lin G, Tang J, Chen Y, Chen L, et al. Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33\/ST2 expression. Parasit Vectors. 2019;12:302.","journal-title":"Parasit Vectors."},{"key":"3866_CR69","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1002\/jcp.27537","volume":"234","author":"N Ding","year":"2019","unstructured":"Ding N, Wang Y, Dou C, Liu F, Guan G, Wei K, et al. Physalin D regulates macrophage M1\/M2 polarization via the STAT1\/6 pathway. J Cell Physiol. 2019;234:8788\u201396.","journal-title":"J Cell Physiol."},{"key":"3866_CR70","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3892\/mmr.2017.6702","volume":"16","author":"D Hu","year":"2017","unstructured":"Hu D, Hu Y, Xu W, Yu H, Yang N, Ni S, et al. miR203 inhibits the expression of collagenrelated genes and the proliferation of hepatic stellate cells through a SMAD3dependent mechanism. Mol Med Rep. 2017;16:1248\u201354.","journal-title":"Mol Med Rep."},{"key":"3866_CR71","doi-asserted-by":"publisher","first-page":"143995","DOI":"10.1016\/j.gene.2019.143995","volume":"715","author":"X Yang","year":"2019","unstructured":"Yang X, Li X, Lin Q, Xu Q. Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K\/Akt signaling pathway via PIK3CA. Gene. 2019;715:143995.","journal-title":"Gene."},{"key":"3866_CR72","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/exd.13164","volume":"26","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhong JL, Hou N, Sun Y, Ma B, Nisar MF, et al. MicroRNA Let-7b inhibits keratinocyte migration in cutaneous wound healing by targeting IGF2BP2. Exp Dermatol. 2017;26:116\u201323.","journal-title":"Exp Dermatol."},{"key":"3866_CR73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12964-018-0271-9","volume":"16","author":"Y Wu","year":"2018","unstructured":"Wu Y, Liu L, Bian C, Diao Q, Nisar MF, Jiang X, et al. MicroRNA let-7b inhibits keratinocyte differentiation by targeting IL-6 mediated ERK signaling in psoriasis. Cell Commun Signal. 2018;16:58.","journal-title":"Cell Commun Signal."},{"issue":"7","key":"3866_CR74","doi-asserted-by":"publisher","first-page":"11216","DOI":"10.1002\/jcb.28397","volume":"120","author":"M Wang","year":"2019","unstructured":"Wang M, Ouyang J, Li H. CERNA2: A predictor for clinical progression and poor prognosis in cervical carcinoma. J Cell Biochem. 2019;120(7):11216\u201321.","journal-title":"J Cell Biochem."},{"key":"3866_CR75","doi-asserted-by":"crossref","first-page":"101042831771927","DOI":"10.1177\/1010428317719274","volume":"39","author":"H Li","year":"2017","unstructured":"Li H, Zhao L, Zhang Z, Zhang H, Ding C, Su Z. Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2. Tumour Biol. 2017;39:1010428317719274.","journal-title":"Tumour Biol."},{"key":"3866_CR76","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1002\/jcb.26606","volume":"119","author":"PW Lu","year":"2018","unstructured":"Lu PW, Li L, Wang F, Gu YT. Effects of long non-coding RNA HOST2 on cell migration and invasion by regulating MicroRNA let-7b in breast cancer. J Cell Biochem. 2018;119:4570\u201380.","journal-title":"J Cell Biochem."},{"key":"3866_CR77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/leu.2012.242","volume":"27","author":"M Nishi","year":"2013","unstructured":"Nishi M, Eguchi-Ishimae M, Wu Z, Gao W, Iwabuki H, Kawakami S, et al. Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements. Leukemia. 2013;27:389\u201397.","journal-title":"Leukemia."},{"key":"3866_CR78","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.bbagrm.2012.06.001","volume":"1819","author":"W Hou","year":"2012","unstructured":"Hou W, Tian Q, Steuerwald NM, Schrum LW, Bonkovsky HL. The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim Biophys Acta. 2012;1819:1113\u201322.","journal-title":"Biochim Biophys Acta."},{"key":"3866_CR79","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1074\/jbc.M116.773291","volume":"292","author":"K McDaniel","year":"2017","unstructured":"McDaniel K, Huang L, Sato K, Wu N, Annable T, Zhou T, et al. The let-7\/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury. J Biol Chem. 2017;292:11336\u201347.","journal-title":"J Biol Chem."},{"key":"3866_CR80","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exppara.2017.09.024","volume":"182","author":"N Tang","year":"2017","unstructured":"Tang N, Wu Y, Cao W, Liang Y, Gao Y, Hu L, et al. Lentivirus-mediated over-expression of let-7b microRNA suppresses hepatic fibrosis in the mouse infected with Schistosoma japonicum. Exp Parasitol. 2017;182:45\u201353.","journal-title":"Exp Parasitol."},{"key":"3866_CR81","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","volume":"6","author":"J Zhou","year":"2018","unstructured":"Zhou J, Li X, Wu X, Zhang T, Zhu Q, Wang X, et al. Exosomes released from tumor-associated macrophages transfer miRNAs that induce a Treg\/Th17 cell imbalance in epithelial ovarian cancer. Cancer Immunol Res. 2018;6:1578.","journal-title":"Cancer Immunol Res."},{"key":"3866_CR82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijbiomac.2018.06.033","volume":"118","author":"X Pei","year":"2018","unstructured":"Pei X, Wang X, Li H. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448\/IDO. Int J Biol Macromol. 2018;118:24\u201330.","journal-title":"Int J Biol Macromol."},{"key":"3866_CR83","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/imr.12164","volume":"259","author":"CM Finlay","year":"2014","unstructured":"Finlay CM, Walsh KP, Mills KH. Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol Rev. 2014;259:206\u201330.","journal-title":"Immunol Rev."},{"key":"3866_CR84","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/imcb.12160","volume":"96","author":"S Zhou","year":"2018","unstructured":"Zhou S, Qi Q, Wang X, Zhang L, Xu L, Dong L, et al. SjHSP60 induces CD4(+) CD25(+) Foxp3(+) Tregs via TLR4-Mal-drived production of TGF-beta in macrophages. Immunol Cell Biol. 2018;96:958\u201368.","journal-title":"Immunol Cell Biol."},{"key":"3866_CR85","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pt.2013.12.009","volume":"30","author":"C Chuah","year":"2014","unstructured":"Chuah C, Jones MK, Burke ML, McManus DP, Gobert GN. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014;30:141\u201350.","journal-title":"Trends Parasitol."},{"key":"3866_CR86","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2567.2004.02083.x","volume":"114","author":"KP Singh","year":"2005","unstructured":"Singh KP, Gerard HC, Hudson AP, Reddy TR, Boros DL. Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology. 2005;114:410\u20137.","journal-title":"Immunology."},{"key":"3866_CR87","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1172\/JCI124725","volume":"129","author":"N Anandagoda","year":"2019","unstructured":"Anandagoda N, Willis JC, Hertweck A, Roberts LB, Jackson I, Gokmen MR, et al. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest. 2019;129:1257\u201371.","journal-title":"J Clin Invest."},{"key":"3866_CR88","doi-asserted-by":"publisher","first-page":"e1003451","DOI":"10.1371\/journal.ppat.1003451","volume":"9","author":"S Kelada","year":"2013","unstructured":"Kelada S, Sethupathy P, Okoye IS, Kistasis E, Czieso S, White SD, et al. miR-182 and miR-10a are key regulators of Treg specialisation and stability during schistosome and leishmania-associated inflammation. PLoS Pathog. 2013;9:e1003451.","journal-title":"PLoS Pathog."},{"key":"3866_CR89","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1096\/fj.201700520RR","volume":"32","author":"D Zhu","year":"2018","unstructured":"Zhu D, Lyu L, Shen P, Wang J, Chen J, Sun X, et al. rSjP40 protein promotes PPARgamma expression in LX-2 cells through microRNA-27b. FASEB J. 2018;32:4798\u2013803.","journal-title":"FASEB J."},{"key":"3866_CR90","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","volume":"50","author":"CJ Guo","year":"2009","unstructured":"Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol. 2009;50:766\u201378.","journal-title":"J Hepatol."},{"key":"3866_CR91","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1756-3305-7-148","volume":"7","author":"D Zhu","year":"2014","unstructured":"Zhu D, He X, Duan Y, Chen J, Wang J, Sun X, et al. Expression of microRNA-454 in TGF-beta1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum. Parasit Vectors. 2014;7:148.","journal-title":"Parasit Vectors."},{"key":"3866_CR92","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/liv.12660","volume":"35","author":"W Dai","year":"2015","unstructured":"Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C, et al. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Liver Int. 2015;35:1234\u201343.","journal-title":"Liver Int."},{"key":"3866_CR93","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1111\/jcmm.13819","volume":"22","author":"D Zhu","year":"2018","unstructured":"Zhu D, Yang C, Shen P, Chen L, Chen J, Sun X, et al. rSjP40 suppresses hepatic stellate cell activation by promoting microRNA-155 expression and inhibiting STAT5 and FOXO3a expression. J Cell Mol Med. 2018;22:5486\u201393.","journal-title":"J Cell Mol Med."},{"key":"3866_CR94","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/jcb.26475","volume":"119","author":"R Tao","year":"2018","unstructured":"Tao R, Fan XX, Yu HJ, Ai G, Zhang HY, Kong HY, et al. MicroRNA-29b-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL1A1 and COL3A1. J Cell Biochem. 2018;119:3199\u2013209.","journal-title":"J Cell Biochem."},{"key":"3866_CR95","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.intimp.2019.01.007","volume":"69","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Dang Z, Chong S. Mmu-miR-92a-2-5p targets TLR2 to relieve Schistosoma japonicum-induced liver fibrosis. Int Immunopharmacol. 2019;69:126\u201335.","journal-title":"Int Immunopharmacol."},{"key":"3866_CR96","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2014.03.015","volume":"71","author":"M Wang","year":"2014","unstructured":"Wang M, Abais JM, Meng N, Zhang Y, Ritter JK, Li P-L, et al. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase. Free Radic Biol Med. 2014;71:109\u201320.","journal-title":"Free Radic Biol Med."},{"issue":"10","key":"3866_CR97","doi-asserted-by":"publisher","first-page":"16316","DOI":"10.1002\/jcb.29053","volume":"120","author":"A Movahedpour","year":"2019","unstructured":"Movahedpour A, Ahmadi N, Ghasemi Y, Savardashtaki A, Shabaninejad Z. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: current status and future perspectives. J Cell Biochem. 2019;120(10):16316\u201329.","journal-title":"J Cell Biochem."},{"key":"3866_CR98","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/qjmed\/hcz158","volume":"112","author":"A Abdollahi","year":"2019","unstructured":"Abdollahi A, Rahmati S, Ghaderi B, Sigari N, Nikkhoo B, Sharifi K, et al. A combined panel of circulating microRNA as a diagnostic tool for detection of the non-small cell lung cancer. QJM. 2019;112:779\u201385.","journal-title":"QJM."},{"key":"3866_CR99","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2174\/1389450120666190708100308","volume":"20","author":"SM Parizadeh","year":"2019","unstructured":"Parizadeh SM, Jafarzadeh-Esfehani R, Ghandehari M, Hasanzadeh M, Parizadeh SMR, Hassanian SM, et al. Circulating and tissue microRNAs as biomarkers for ovarian cancer prognosis. Curr Drug Targets. 2019;20:1447\u201360.","journal-title":"Curr Drug Targets."},{"key":"3866_CR100","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mc.20712","volume":"50","author":"J Xu","year":"2011","unstructured":"Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog. 2011;50:136\u201342.","journal-title":"Mol Carcinog."},{"key":"3866_CR101","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1073\/pnas.0813371106","volume":"106","author":"K Wang","year":"2009","unstructured":"Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA. 2009;106:4402\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3866_CR102","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13071-015-0806-5","volume":"8","author":"L Zhu","year":"2015","unstructured":"Zhu L, Dao J, Du X, Li H, Lu K, Liu J, et al. Altered levels of circulating miRNAs are associated Schistosoma japonicum infection in mice. Parasit Vectors. 2015;8:196.","journal-title":"Parasit Vectors."},{"key":"3866_CR103","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1756-3305-6-272","volume":"6","author":"X He","year":"2013","unstructured":"He X, Sai X, Chen C, Zhang Y, Xu X, Zhang D, et al. Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy. Parasit Vectors. 2013;6:272.","journal-title":"Parasit Vectors."},{"key":"3866_CR104","doi-asserted-by":"publisher","first-page":"e0003965","DOI":"10.1371\/journal.pntd.0003965","volume":"9","author":"P Cai","year":"2015","unstructured":"Cai P, Gobert GN, You H, Duke M, McManus DP. Circulating miRNAs: potential novel biomarkers for hepatopathology progression and diagnosis of Schistosomiasis japonica in two murine models. PLoS Negl Trop Dis. 2015;9:e0003965.","journal-title":"PLoS Negl Trop Dis."},{"key":"3866_CR105","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ebiom.2018.10.048","volume":"37","author":"P Cai","year":"2018","unstructured":"Cai P, Mu Y, Olveda RM, Ross AG, Olveda DU, McManus DP. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis. Ebiomedicine. 2018;37:334\u201343.","journal-title":"Ebiomedicine."},{"key":"3866_CR106","first-page":"378","volume":"215","author":"T Meningher","year":"2017","unstructured":"Meningher T, Lerman G, Regev-Rudzki N, Gold D, Ben-Dov IZ, Sidi Y, et al. Schistosomal microRNAs isolated from extracellular vesicles in sera of infected patients: a new tool for diagnosis and follow-up of human schistosomiasis. J Infect Dis. 2017;215:378\u201386.","journal-title":"J Infect Dis."},{"key":"3866_CR107","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1721727X1301100115","volume":"11","author":"YP Zhou","year":"2013","unstructured":"Zhou YP, Zhang SL, Cheng D, Li HR, Tang ZM, Xue J, et al. Preliminary exploration on anti-fibrosis effect of kaempferol in mice with Schistosoma japonicum infection. Eur J Inflamm. 2013;11:161\u20138.","journal-title":"Eur J Inflamm."},{"key":"3866_CR108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exppara.2018.05.004","volume":"191","author":"NA Parreira","year":"2018","unstructured":"Parreira NA, Ramalho FS, Augusto MJ, Silva DM, Prado CM, Elias Junior J, et al. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. Exp Parasitol. 2018;191:9\u201318.","journal-title":"Exp Parasitol."},{"key":"3866_CR109","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijpddr.2016.01.003","volume":"6","author":"YR Yu","year":"2016","unstructured":"Yu YR, Ni XQ, Huang J, Zhu YH, Qi YF. Taurine drinking ameliorates hepatic granuloma and fibrosis in mice infected with Schistosoma japonicum. Int J Parasitol Drugs Drug Resist. 2016;6:35\u201343.","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"3866_CR110","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s12639-014-0606-4","volume":"40","author":"NM El-Sayed","year":"2016","unstructured":"El-Sayed NM, Fathy GM, Abdel-Rahman SA, El-Shafei MA. Cytokine patterns in experimental Schistosomiasis mansoni infected mice treated with silymarin. J Parasit Dis. 2016;40:922\u20139.","journal-title":"J Parasit Dis."},{"key":"3866_CR111","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12639-018-0997-8","volume":"42","author":"MH Hegab","year":"2018","unstructured":"Hegab MH, Abd-Allah SH, Badawey MS, Saleh AA, Metwally AS, Fathy GM, et al. Therapeutic potential effect of bone marrow-derived mesenchymal stem cells on chronic liver disease in murine Schistosomiasis mansoni. J Parasit Dis. 2018;42:277\u201386.","journal-title":"J Parasit Dis."},{"key":"3866_CR112","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jcp.20412","volume":"204","author":"DL Boros","year":"2005","unstructured":"Boros DL, Singh KP, Gerard HC, Hudson AP, White SL, Cutroneo KR. A novel nonsteroidal antifibrotic oligo decoy containing the TGF-beta element found in the COL1A1 gene which regulates murine schistosomiasis liver fibrosis. J Cell Physiol. 2005;204:370\u20134.","journal-title":"J Cell Physiol."},{"key":"3866_CR113","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1017\/S0031182011001855","volume":"139","author":"G Cheng","year":"2012","unstructured":"Cheng G, Jin Y. MicroRNAs: potentially important regulators for schistosome development and therapeutic targets against schistosomiasis. Parasitology. 2012;139:669\u201379.","journal-title":"Parasitology."},{"key":"3866_CR114","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language. Cell. 2011;146:353\u20138.","journal-title":"Cell"},{"key":"3866_CR115","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/CIRCRESAHA.111.247916","volume":"110","author":"E van Rooij","year":"2012","unstructured":"van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res. 2012;110:496\u2013507.","journal-title":"Circ Res."},{"key":"3866_CR116","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pt.2015.09.003","volume":"32","author":"P Cai","year":"2016","unstructured":"Cai P, Gobert GN, McManus DP. MicroRNAs in parasitic helminthiases: current status and future perspectives. Trends Parasitol. 2016;32:71\u201386.","journal-title":"Trends Parasitol."},{"key":"3866_CR117","doi-asserted-by":"publisher","first-page":"1801809","DOI":"10.1002\/advs.201801809","volume":"6","author":"J Wu","year":"2019","unstructured":"Wu J, Huang J, Kuang S, Chen J, Li X, Chen B, et al. Synergistic microRNA therapy in liver fibrotic rat using MRI-visible nanocarrier targeting hepatic stellate cells. Adv Sci. 2019;6:1801809.","journal-title":"Adv Sci."},{"key":"3866_CR118","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/21691401.2018.1453830","volume":"46","author":"S He","year":"2018","unstructured":"He S, Guo W, Deng F, Chen K, Jiang Y, Dong M, et al. Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD. Artif Cells Nanomed Biotechnol. 2018;46:217\u201328.","journal-title":"Artif Cells Nanomed Biotechnol."},{"key":"3866_CR119","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1002\/jcb.26073","volume":"118","author":"H Tang","year":"2017","unstructured":"Tang H, Liang YB, Chen ZB, Du LL, Zeng LJ, Wu JG, et al. Soluble egg antigen activates M2 macrophages via the STAT6 and PI3K pathways, and Schistosoma japonicum alternatively activates macrophage polarization to improve the survival rate of septic mice. J Cell Biochem. 2017;118:4230\u20139.","journal-title":"J Cell Biochem."},{"key":"3866_CR120","first-page":"81","volume":"26","author":"DY Chu","year":"2008","unstructured":"Chu DY, Li CL, Li J, Luo F, Zheng MJ, Wu Q, et al. Effect of paeoniflorin on secretion of TGF-beta1 from macrophages in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008;26:81\u20135.","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3866-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3866-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3866-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T19:32:35Z","timestamp":1609183955000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3866-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3866"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3866-0","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"13 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"611"}}